Dissecting immunosuppression in brain tumor tissue

Description of the granted funding

Immunotherapy is associated with efficient and long-lasting treatment responses in several cancers, but only a subpopulation of patients respond to current approaches. Partly because of this, it is important to further stratify the patients based on their predicted immune response. In the project, we will categorize patients based on the type of immunosuppression in tumor microenvironment and investigate which regulators drive tumor-induced immunosuppression in brain tumors. Computing, analysis of large-scale measurement data, wet-lab experimentation, and patient-derived brain tumor material will be used. The obtained results aim to clarify which treatment options could work the best for each patient. The project can also lead to the identification of novel treatment targets for personalized immunotherapy.
Show more

Starting year

2020

End year

2022

Granted funding

Kirsi Johanna Granberg Orcid -palvelun logo
250 000 €

Kirsi Johanna Rautajoki Orcid -palvelun logo
250 000 €

Role in consortium of the Academy of Finland

Leader

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

333545

Fields of science

Biomedicine

Research fields

Biolääketieteet

Themes

Nuori tutkijasukupolvi 2019

Identified topics

cancer